Medicamen Biotech: Board Meeting Intimation for Considering Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30 2024

MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30 2024.